NCT02494505View on ClinicalTrials.gov

Interest of Mycophenolate for CIDP Weaning

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 18, 2013

Primary Completion Date

May 9, 2018

Study Completion Date

May 9, 2018

Conditions
Chronic Inflammatory Demyelinating Polyradiculopathy
Interventions
DRUG

Mycophenolate Mofetil

2g/day per os

DRUG

placebo

Trial Locations (1)

75013

Neurology - pitié salpetrière hospital, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02494505 - Interest of Mycophenolate for CIDP Weaning | Biotech Hunter | Biotech Hunter